武田薬品工業株式会社

549300ZLMVP4X0OGR454

The entity

Status: Active
LEI status: Issued and current
Category: Company
Legal form: 株式会社 (T417)
Jurisdiction: Japan
Entity created: January 12, 1925

Address

Country: Japan
Legal address: 中央区道修町四丁目１番１号541-0045 大阪Japan (JP-27)

Identifier

LEI: 549300ZLMVP4X0OGR454
Registered: November 15, 2013 at 03:01 AM UTC
Last updated: November 6, 2025 at 08:50 PM UTC
Next renewal: December 2, 2026 at 10:58 AM UTC
Issuer: Bloomberg (5493001KJTIIGC8Y1R12)
Registered with: Companies Registration (RA000412)
Identifier: 1200-01-077461
Verified against: Companies Registration (RA000412)
Verified as: 1200-01-077461
Corroboration: Confirmed against a public register
GLEIF conformity: Meets the standard

Corporate structure

Owns11

Baxalta Innovations GmbH
Direct subsidiaryAustria
BioLife Plazma Hungary Korlátolt Felelősségű Társaság
Direct subsidiaryHungary
TAKEDA AUSTRIA GMBH
Held through a subsidiaryAustria
TAKEDA BELGIUM
Direct subsidiaryBelgium
TAKEDA GMBH
Held through a subsidiaryGermany
TAKEDA IRELAND LIMITED
Held through a subsidiaryIreland
Takeda Manufacturing Austria AG
Direct subsidiaryAustria
Takeda Pharmaceuticals Czech Republic s.r.o
Direct subsidiaryCzechia
Takeda Pharmaceuticals International AG
Direct subsidiarySwitzerland
TAKEDA PHARMACEUTICALS U.S.A., INC.
Direct subsidiaryUnited States
TAKEDA U.S. FINANCING, INC.
Direct subsidiaryUnited States

Why no parent is reported

No direct parent reportedNo ultimate parent reported: The parent is one or more private individuals

Machine access

REST: https://lei.online/v1/entities/549300ZLMVP4X0OGR454This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search